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When a health authority wants to identify areas disproportionately affected by a 
disease, a good starting point is to map crude health data. However, data from small 
populations can be unstable and overestimate the disease risk, or data may be incomplete. 
These problems can be partially remedied through statistical smoothers.  
Two spatiotemporal mapping methods are compared in this study, the Waller model 
and Bayesian Maximum Entropy (BME). The Waller model belongs to the established 
family of Bayesian hierarchical models, ‘hierarchical’ because uncertainty within the model 
is measured indefinitely through a series of parameters and hyperparameters. BME, crafted at 
UNC, uses covariance to supply prior knowledge, and ignores uncertainty in prior 
parameters. These methods were applied to 69,000 records of cardiopulmonary medical visits 
in the United Arab Emirates. BME was found to be a stronger smoother of health data. Rates 
of medical visits were found to rise sharply during summer months.  
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4 Introduction to Disease Mapping 
 
Mapping health data is a common method used to uncover spatial and temporal 
patterns of disease. With the improvement of Geographic Information Systems, and 
availability of health data for towns, municipalities, and counties, the resulting maps describe 
disease patterns at an increasingly precise spatial scale (Richardson, 2004). However useful, 
mapping health data poses intriguing questions. Towns, municipalities or rural counties with 
a small population may by random chance have a very high or very low rate, accompanied 
with an unreliable variance. The small population size and the rare nature of some diseases 
prevent the disease rate from stabilizing at its true, unknown value. On the simplest kind of 
disease map, these extreme values of disease rates can distort the true risk surface of the 
study region, suggesting a higher or lower risk than is the case for certain areas (Richardson, 
2004). The finer the geographic resolution of a study region, the more likely that such 
extreme values, also referred to as the “small number problem,” will exist on a disease map 
(Goovaerts, 2005).  
To counteract this tendency, many statistical mapping techniques have been 
developed specifically for disease mapping, many within the Bayesian modeling framework. 
A Bayesian modeling approach involves estimating a prior probability density function of the 
disease rate at given space-time points, and then using observed data and other inputs in 
order to create a posterior density function. The posterior density function estimates values of 
health risk for different space-time points in the study region. Bayesian hierarchical modeling 
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is a particular subset in which the parameters of the prior density function are characterized 
by their own hyperprior distributions, whose parameters may be further defined. Thus, a 
‘hierarchy’ emerges. In health mapping, often the Poisson probability function is used to 
estimate the disease rate at any given space-time point, and the parameter of the Poisson 
distribution is itself represented as a random variable (often with a Gamma distribution) 
(Lawson 2003). Among the most commonly used is the Besag, York, Mollie (BYM) model 
(Best, 2005). The BYM model is distinguished by its use of a conditional autoregressive 
prior in which weight is placed on spatial correlation among adjacent tracts of land. A 
comparison study by Lawson (2000) found the BYM model to be the ‘most robust’ model 
with a spatial structure. The follow-up Waller model, named so for its architect, builds upon 
the BYM framework by incorporating adjacency in time as well as in space.  
Various Bayesian hierarchical models have been used in recent health risk studies. 
Researchers in Finland mapped the occurrence of acute myocardial infarction (heart attacks) 
in Finnish counties with alternating regions of high and low population density. They used 
the Bayesian hierarchical framework to detect potential environmental factors behind the 
higher rate of heart attacks in eastern Finland (Kajander, 2003). Similarly, Spanish 
researchers used a hierarchical Poisson-gamma model and an empirical Bayes analysis to 
explore the link between cardiovascular disease mortality in Comunidad Valencia and water 
hardness (Ferrandiz, 2004). 
However, although common, the Bayesian hierarchical framework may not always be 
the best approach to disease mapping in certain situations. Indeed, different mapping 
methods are necessary because each addresses the debate over how to deal with extreme 
rates, or whether extreme rates should be dealt with, in a unique way. For example, other 
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different estimation approaches have been shown to yield alternative results when study 
tracts are of unequal size (Goovaerts 2008). This paper compares two different mapping 
estimation approaches for mapping the spatial and temporal patterns of diseases that may be 
linked to air pollution in the United Arab Emirates (UAE): the Waller space-time method, 
executed through the computer software WinBUGS, and the lesser-known Bayesian 
Maximum Entropy (BME) geostatistical mapping approach. The BME approach may be 
better suited to modeling UAE health risks because of that country’s alternating regions of 
high and low population density and the absence or non-availability of firmly defined, 
regularly-sized tracts (such as counties or census blocks). BME can also be constructed in a 
way that constrains the amount of smoothing performed, so that estimated rates cannot 
deviate from observed rates with uninhibited agility. The resulting disease maps are then 
preliminarily compared to maps of particulate matter concentrations in the same study area. 
 
5 Literature Review 
 
5.1 Background on United Arab Emirates 
 
The health data used in this research paper comes from the United Arab Emirates 
(UAE), a Gulf country in the Middle East. Health patterns have changed extensively in the 
UAE since its economic transformation beginning in the 1960s. Economic profits have been 
invested into the improvement of health infrastructure, and health services are widely 
available (Shihab, 2001). Several early 1990s assessments found good coverage in terms of 
the availability and distribution of beds, physicians, dentists, and other medical workers 
throughout the country (Bener, 1993). Much of the UAE population (75% or more) lives in 
cities (Census UAE 2005). Cities usually offer more physicians per population size, as well 
as more opportunities for specialized care (Bener, 1993). Based on an extensive search of 
Google Scholar, spatial and temporal disease patterns have rarely, if ever, been mapped in 
the UAE or other Gulf countries. The maps here are perhaps the first in the region to estimate 
and display spatiotemporal disease patterns. 
Non-communicable diseases and injuries, including diabetes, cancer, CVD, and 
respiratory diseases, have partially usurped infectious diseases as the major health issues in 
the UAE, in terms of number of incidents and deaths. The Health Authority in Abu Dhabi, 
the largest emirate in the UAE and the seat of federal power, provided data on all 2008 
individual medical facility visits, pertaining to the four disease categories above, for the 73% 
of the population in Abu Dhabi registered under the largest insurance provider there. A 
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handful of these diseases were selected for analysis and mapping of their spatial and temporal 
patterns. All of these diseases can be affected by exposure to particulate matter in air, a 
source of air pollution in the UAE (Dominici, 2003). The diseases were identified by their 
codes as laid out in the International Classification of Disease, Ninth Edition: cardiovascular 
diseases (ICD-9 390-448), pneumonia (ICD-9 480-486), asthma (ICD-9 493), chronic 
pulmonary obstructive diseases (ICD-9 490-492, 494-496), and pneumonitis (ICD-9 507).  
 
5.2 Comparisons of Bayesian Non-Bayesian Models Used in Disease Mapping 
 
Several papers previously published compare different Bayesian hierarchical models 
to non-Bayesian methods. Jang (2007) compared hierarchical generalized linear models to a 
pair of Bayesian models, each with a different gamma prior defined by unique parameters. 
The gamma probability density function is a continuous, two-parameter model most often 
featuring a right skew. It is often used as the prior model because the Poisson and gamma 
functions are conjugates. That is, if the prior distribution for the Poisson parameter, λ, is 
assumed to follow a gamma distribution and then a Bayesian method is used to update the 
prior distribution using observed data, then the posterior (or updated) distribution also will 
have a gamma distribution (Lawson 2003). Jang (2997) found that no major differences 
existed between the three Poisson priors they tested upon the following three data sets: low 
birth weight and cancer mortality in South Carolina, and lip cancer incidence in Scotland. 
Richardson (2004) compared the regular BYM model, a modified BYM model with a 
double-exponential prior distribution (instead of a normal distribution), and a semi-
parametric spatial mixture model. They used simulated disease risk data from Yorkshire, 
England. The BYM model, being a parametric model where information anywhere is used to 
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smooth output everywhere, can as a consequence produce rate estimates that are overly 
smooth. A semi-parametric model, on the other hand, divides the study region into discrete 
sections, and borrowing of information does not extend beyond these section boundaries. 
Such a model may therefore be better suited for a disease risk surface featuring sudden 
changes in rate values, and prevent over-smoothing. A double exponential distribution might 
also be expected to produce less smoothing compared to the normal distribution, due to its 
skewed shaped. The researchers compared these three models with respect to their 
sensitivity, or ability to recognize actual increases in disease rate, as well as their specificity, 
or ability to smooth out background noise in areas where no true risk increase exists. They 
found the regular and modified BYM models mirrored each other in all major aspects, while 
the semi-parametric mixture model could better, but not flawlessly, detect subtle, legitimate 
increases in disease risk, as long as the variances of the estimated rates were low. All three 
models were adept at smoothing regions with no true elevated risk (high specificity).  
Best (2005) compared five mapping techniques using data simulated in accordance to 
actual NO2 (nitrogen dioxide) levels and hypothetical pollution point sources in a rural 
English town and surrounding areas. The models included a gamma moving average model 
and an exponential parametric model, Richardson’s semi-parametric mixture model, BYM, 
and a spatial partition model. Each model had strengths and weaknesses. The gamma and 
exponential models yielded overly smooth results. The partition model output was also 
excessively smooth, but along with BYM, was the most accurate model for representing 
medium risk areas. The mixture model displayed legitimate increases in disease risk, as 
Richardson previously showed, but was less effective at smoothing out background noise. 
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Three separate generalized linear models (GLMs) with a Poisson distribution were 
used to model lung cancer incidence rates in the Haut-Rhin department of France (Sauleau, 
2007). A different convolution prior was used for each model; a convolution prior includes a 
factor for correlation and for heterogeneity. The intrinsic conditional autoregressive prior 
(CAR) models spatial dependence by adjacency. The joint exponential distance prior 
measures spatial dependency by distance, exp[-(dij/rho)], where d is the distance between 
points i and j and rho is the attenuation factor. The last model used a two-dimensional p-
spline prior. The researchers found that the intrinsic CAR model produced the least smooth 
results, while the p-spline model had the smallest deviance of the posterior mean (a measure 
of how well the model fits the data) and the smallest number of effective model parameters. 
An effective model tries to minimize both of these attributes, so by this metric, the p-spline 
model is preferred.  
5.3 Comparisons of Bayesian Models and Geostatistical Models 
 
BYM and other Bayesian hierarchical models may be the most common approach to 
mapping disease data, but such methods will produce imperfect results if the model inputs 
are not carefully chosen. For example, the BYM model requires the modeler to assign the 
weight of influence of neighboring tracts on an estimated value; however, these weights are 
often chosen arbitrarily, without explanation (Goovaerts, 2008). BYM is most suitable for 
study regions whose tracts are similarly shaped and sized; this often does not hold for study 
regions without clear municipal boundaries and with nascent health data collection systems. 
Thus, other mapping approaches might be preferable for mapping health data in the United 
Arab Emirates and other countries which are just starting to form organized, routine 
environmental and health surveillance systems.  
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A geostatistical approach to disease mapping has been studied extensively by 
Goovaerts. His 2005 paper compared the geostatistical Poisson kriging tool to three early 
simple map smoothers: a population weighted disease map, an empirical Bayes smoother 
with a global mean, and an empirical Bayes smoother with a local mean. Empirical Bayes 
analysis was the predecessor of full Bayesian analysis during an era in which computational 
power was limited. Under empirical Bayes smoothing, the disease risk for each location is 
calculated as a weighted sum of the rate observed at that point and a prior mean – either a 
global or local prior mean.  
Poisson kriging, on the other hand, is an unbiased estimator that calculates disease 
risk at each location as a linear combination of the neighboring observed rates, while 
minimizing the mean square error of prediction. A study of breast cancer mortality (relatively 
frequent) and cervical cancer mortality (relatively rare) in the New England States found that 
all four methods produce maps with estimated rates similar to the observed rates (Goovaerts, 
2005). Compared to the three simpler methods, the Poisson kriging method produced the 
most accurate measurements, especially when spatial correlation existed between data points. 
Variance in the Poisson kriging map was also relatively low. The small variance might, 
according to Goovaerts’ 2008 paper, be due to the disregard the Poisson kriging method has 
for the variance possible in the covariance model. Although the covariance model is 
estimated, it is not accompanied by the possible size of the error associated with that model. 
In the same paper, the fully Bayes BYM model was compared to Poisson kriging. The two 
methods were applied to lung and cervical cancer data in a study region with uniformly 
shaped tracts, and a separate study region with a patternless grid. Both study regions were in 
the United States. Goovaerts found the greatest difference between BYM and Poisson kriging 
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for differently-shaped tracts, with BYM creating the smoother surface. Poisson kriging was 
better able to highlight areas of elevated risk. Both methods, as expected, reported variance 
higher in those areas with a low population.  
Recently, spatial analyses of health data have progressed to include a temporal 
component. Comparing spatial and spatiotemporal analyses have found that modeling the 
space-time interaction term, and modeling the space and time dimensions simultaneously, 
can lead to preferable results, despite the increased computational workload necessitated by 
adding a temporal component (Abellan, 2007).  
6 Data and Methods 
 
6.1 Data used in the study 
 
This research used health data obtained from the Health Authority-Abu Dhabi 
(HAAD). HAAD is the main agency for promoting public health in Abu Dhabi. HAAD 
provided four categories of previously collected health outcome data for the purposes of the 
study1: mortality, morbidity, birth, and cancer. Except for certain cancer and certain birth 
outcome data, the data were provided as lists of individual patient encounters with a few 
descriptive parameters. Out of concern for medical privacy and confidentiality of the 
patients, patient identifiers were removed, and the data were securely stored. A 
confidentiality and privacy agreement was signed with HAAD. A detailed description of the 
health data is provided in Table 1.   
In order to produce accurate spatiotemporal disease risk maps, the data needed to 
meet certain criteria. At the minimum, a date and a place must accurately locate each medical 
event. Additional information useful for stratification and sensitivity analyses include gender, 
age, and nationality information.  
The spatial information in the four original datasets had varying degrees of precision. 
The mortality data gave at best only a vague spatial location in the vicinity of a city. Birth 
                                                 
1The research team would like to thank Dr. Jens Thomsen, Mr. Mohammed Al-Jadaa, and 
their colleagues at HAAD for their great dedication and help in procuring the necessary UAE 
health data. Full data ownership rights belong to HAAD.  
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data was spatially referenced by neighborhood or street in the city of parental residence. The 
spatial location of morbidity (diabetes, cancer, respiratory diseases, and cardiovascular 
diseases) data was identified by the location of the medical facility where the encounter took 
place. After completing an initial mapping of each dataset, the research group chose to focus 
on morbidity data for two reasons: 1) elevated levels of particulate matter in outdoor air in 
outdoor air have been shown to affect people with these diseases and 2) geographic 
information on locations where patients were treated is available.  
 1
2
 
Outcome 
 
Year Health 
Conditions 
Included 
Population 
Included 
Total Number 
of Medical 
Records in Data 
Set 
Demographic 
Information 
Included 
Geographic 
Information 
Included 
Birth 2008 Birth weight 
 
Entire Abu 
Dhabi 
Population 
c. 39,000 Gender 
Parent 
nationality 
Date of birth 
Home street or 
neighborhood 
and city 
Birth 
(Aggregated by 
demographic 
and geographic 
parameters) 
2006-2008 Live/Still births 
 
Entire Abu 
Dhabi 
population, 
although missing 
for some regions 
for some time 
periods 
N/A (data 
represents 
aggregation of 
individual 
records) 
Gender 
Nationality 
Month/year of 
birth 
 
Some 
city/hospital 
information 
Birth 2008 Congenital 
abnormalities 
Gestational age 
Head 
circumference 
Birth weight 
Full baby health 
status 
APGAR score 
Babies born at 
Mafraq Hospital 
(Abu Dhabi 
outskirts) 
916 Gender 
Nationality 
Month/year of 
birth 
 
Place of Usual 
Residence (City) 
Mortality 2008 All causes of 
death (listed by 
ICD code of 
specific cause) 
Entire Abu 
Dhabi 
Population 
2663 Gender 
Nationality 
City or region of 
death 
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Date of death 
Visits to 
medical facility 
(hospital, clinic, 
doctor’s office, 
pharmacy) 
 
2008 Cardiovascular 
diseases (ICD-9 
390-459) 
Respiratory 
diseases (ICD-9 
460-519) 
Cancer (ICD-9 
140-239) 
Diabetes (ICD-9 
250) 
Abu Dhabi 
population 
subscribing to 
Abu Dhabi’s 
largest insurance 
provider, Daman 
(estimated by 
HAAD to be 
73% of the Abu 
Dhabi 
population) 
564,220 visits; 
69,103 of these 
represented the 
principal 
diagnoses of 
selected CVD 
and respiratory 
disease within 
Abu Dhabi 
emirate used in 
the study.  
Gender 
Nationality 
Date of visit 
Age 
Medical facility 
visited 
Cancer 
(Aggregated by 
demographic 
parameters) 
1998-2007 Cancers (ICD-10 
C00-C95) 
Entire UAE 
population 
N/A (data 
represents 
aggregation of 
individual 
records) 
Gender 
Nationality 
Year of 
diagnosis 
None 
Cancer 
(Aggregated by 
geographic 
parameters) 
1998-2007 Cancers (ICD-10 
C00-C95) 
Entire UAE 
population 
N/A (data 
represents 
aggregation of 
individual 
records) 
Nationality Place of 
residence (city) 
 
Table 1. Summary of all health data collected from the United Arab Emirates, including those not analyzed extensively for the purposes of this study.
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6.2 Data preparation 
 
This study focuses on selected CVD and respiratory morbidity data. The original 
morbidity data file contained the following information:  
• the ICD code specifying the type of illness,  
• the name of the attending medical facility (hospital, pharmacy, clinic, center, 
or other),  
• the gender, date of birth, and nationality of the patient,  
• the classification of the diagnosis as a principle or secondary diagnosis,  
• the date of the encounter,  
• and a unique encounter (not patient) identifier which turned out to be 
irrelevant for the purposes of the study.  
Although some patient personal information was included, it was impossible in the absence 
of a name or unique patient identifier to ascertain which visits were repeated visits by the 
same patient. The number of individuals visiting medical facilities could therefore not be 
determined. The dilemma can be illustrated by a patient reporting to the hospital to treat an 
asthma attack. If the patient returns for two additional follow-up visits, then a single 
exacerbation of asthma is coded in the dataset as three separate exacerbations. In light of this 
dilemma, it was decided that mapping “medical visitations” of diseases was the best way to 
treat the data.  
Since date of birth was provided, the year of birth was separated and then subtracted 
from 2008 (the year in which the encounters occurred). Thus the age of each patient was 
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determined. All secondary diagnoses were removed from the data so as to remove ambiguity 
of analyzing principle and secondary diagnoses concurrently. Based on the nationality given, 
each patient was coded as being either “Emirati” or as “Other”.  
In order to map the data, each spatial location needed to have a longitudinal and 
latitudinal coordinate. To simplify the process, HAAD provided the research team with a list 
consisting of the geographic coordinates of approximately 700 Abu Dhabi medical facilities. 
These were modified from their given form as “Degrees/Minutes/Seconds” to decimal-degree 
notation. The coordinates were then manually matched up to the name of the medical facility 
as given in the targeted data set. As the list of 700 facilities did not provide all needed 
coordinates, the remainder was gleaned through Google Earth. A couple dozen known 
medical facility coordinates were compared between Google Earth and the HAAD list to 
verify that the two geographic sources matched up. In the end, 83.7% of the data set was 
spatially referenced with geographic coordinates through a combination of the HAAD list 
and Google Earth. The remaining encounters were disregarded from the data due to lack of a 
spatial location.  
After discarding data without spatial coordinates, there remained some 71,000 visits 
due to specified respiratory and cardiovascular diseases (see ICD codes above) that occurred 
under the auspices of Abu Dhabi’s largest insurance provider, Daman, in 2008, counting all 
ages, all nationalities, and all medical facilities. Although the insurance provider is located in 
Abu Dhabi, it also caters to some residents of the northern emirates. Approximately 2,000 
visits out of the 71,000 occurred at medical facilities in Dubai, Sharjah, or one of the other 
smaller northern emirates. There was no information on what percentage of the population in 
these emirates uses the insurance company in question. Since they constituted such a small 
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portion of the overall dataset and did not provide accurate visiting information for these 
northern emirates, it was thought best to rely solely on encounters that occurred in Abu 
Dhabi emirate, which accounts for approximately 90% of geographic space in the UAE. This 
downsized the total number of visits down to 69,103. Of these, 46,709 visits dealt with 
cardiovascular issues, and 22,394 were a result of respiratory issues. These visits occurred at 
277 separate medical facilities.  
A MatLab program was written in order to aggregate visit counts for each medical 
facility for the entire year. The program was modified so as to aggregate by time periods as 
well, for example, finding the number of visits at a certain location within a three-month time 
period. Time periods of any length may be chosen. The maps presented in the results section 
are based on monthly aggregations, although yearly and quarterly time frames were also 
tested. The result is a space-time point, defined both by its geographic coordinates and by its 
time period. Due to the very few number of visits that occurred in December, these were 
lumped in with the November counts. January counts were disregarded (these were also very 
low), leading to 10 months’ worth of temporal distance.  
As previously mentioned, the visit counts per medical facility accounted for only 73% 
of the population, and 16% of those visits were discarded due to insufficient geographic data. 
Before moving forward with further analysis, the MatLab output was scaled up to 100% in 
recognition of these omissions, first through a multiplication by (100/73), and then a second 
multiplication by (100/84). 
The work described so far yielded counts of visits for respiratory and cardiovascular 
diseases. The next step was to find a rate of the visits for each space-time point. Population 
data at a fine spatial resolution was needed, but not available from either UAE or Abu Dhabi 
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sources. In lieu of official numbers, the research team used population estimates based on the 
2007 LandScanTM Global Population Database. This database uses satellite figures of night-
time light density to predict population densities (see Figure 1). The result was a map of 
population figures that estimated the UAE-wide population (approximately 4.5 million 
people), accurately depicting densely populated areas such as cities and industrialized areas, 
while leaving empty those areas endowed with vast deserts. A distribution of population per 
tract is available in Figure 2.  
 
Figure 1. Map highlighting areas of human habitation in the UAE. Each pink dot represents a specified 
population density, with density increasing with color intensity.  
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Figure 2. Distribution of population densities per tract. It is more common for tracts to have very few 
inhabitants than to be densely populated.  
However, population data is not enough. There must be a way of carving the study 
region into sub-regions or tracts, and of illustrating spatial trends by finding a rate for each 
tract. Then, the number of visits and the population for tract i combine to create a rate for 
tract i. In many circumstances, a study region has been previously carved into administrative 
regions, such as counties or municipalities, and these can serve as tracts. However, the UAE 
does not have this type of administrative set-up; few boundaries exist that delineate the end 
of one administrative unit and the beginning of another. Therefore, the research team created 
these tracts as follows.  
The “Fishnet” tool in the ArcGIS toolbox created a web of small polygons, each 
approximately 1 km2, that was overlaid on the population points. Using the “Near” tool, also 
in the ArcGIS toolbox, each population polygon was assigned to the medical facility nearest 
to it, called its Near ID. Distance was assumed to be “as the crow flies”, in the absence of an 
analysis of nearest distance based on roadways. Using the “dissolve” function, each 
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population polygon with the same Near ID were merged into one large polygon. Thus, 
catchment areas for each medical facility were created.  
Using the “spatial join” feature in ArcGIS, population points were summed up for 
each large population polygon. The number of visits, separated by cardiovascular and 
respiratory diseases, for all medical facilities lying in each large polygon were also summed 
up. It was then possible to find a rate for each large polygon by dividing the sum of visits by 
the total population. If visits were aggregated for a period of time less than 365 days, the 
resulting rates were normalized to a year. For example, monthly rates were multiplied by 
twelve. These rates were mapped to produce an image of the crude health risk for 
cardiovascular and respiratory diseases in Abu Dhabi.  
6.3 Creating Smooth Estimation Maps Via Two Different Methods 
 
There are several reasons to apply a smoothing technique to UAE health data. First, 
although the majority of the population lives in cities, there are still substantial numbers of 
people living in smaller towns and in rural areas. The rate of disease in such areas is prone to 
rapid changes because of the small sample size. Thus, the average disease risk over time may 
vary widely from the rate observed at any single time interval.  
The second reason is that UAE is still in the process of organizing its health oversight 
systems and fine-tuning its systems of data-collection. It is possible that gaps exist in the 
recorded health data. Bayesian statistics can be used to estimate values for these data gaps, 
both spatially and temporally. Two different methods are described below.  
 
6.3.1 Method 1: BME approach  
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Bayesian Maximum Entropy (BME), the first mapping method used, was created at 
the University of North Carolina at Chapel Hill. To download BME software and learn how 
to use it through on-line tutorials, those interested may seek out the BME site at 
(http://www.unc.edu/depts/case/BMElab/) or 
(http://www.unc.edu/mserre/teaching/fall2009/envr468/).  
A full explanation of BME theory can found on Dr. Marc Serre’s class website for 
Temporal GIS, ENVR 468, under lecture notes 
(http://www.unc.edu/mserre/teaching/fall2009/envr468/). A source of additional study on 
space-time theory is located in Temporal GIS: Advanced Functions for Space-Time 
Applications (Christakos, Bogaert, Serre, 2002). A brief overview of the theory follows here.  
The space-time point p is a function of both space and time, or p = f(s,t). BME 
estimates the value of a random variable, x, at space-time points p. A possible realization 
(observation) of x is referred to as χ. The collection of all values of x forms a vector, xmap = 
{x1, x2, … xn} corresponding to the vector of all space-time points, pmap = {p1, p2, … pn}. A 
specific realization of xmap is χmap = { χ1, χ2, … χn }. The specific realization mapped here is 
comprised of the data available for the study.  
Xmap may consist of hard data and soft data. A hard data value is a known value for 
which there is no error. A soft data value, on the other hand, is determined by a probability 
distribution function, because it is thought to be uncertain. Since the HAAD study data was 
scaled up and incomplete, it was treated exclusively as soft data. Soft data points were 
constructed as a uniform probability distribution function, where the lower bound was the 
rate subtracted by (0.5/population) and the upper bound was the sum of the rate and 
(0.5/population). In other words, 
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Xsoft = xobs, ± 0.5/population 
This formation allows data-points with a low population to have a wider range of 
possible rates, a helpful construct since it is precisely these space-time points with low 
population where the value of the observed rate is most prone to variability. If the lower 
bound dipped into negative numbers, it was truncated at zero. In the final data-sets, all space-
time points were treated as soft data points. See Figure 3 for a distribution of interval 
lengths; most are narrow, indicating that most observations are formed on the basis of a large 
population where disease rates are stable. 
 
Figure 3.  Lengths of the soft interval data used as site-specific knowledge in BME. This data pertains to 
respiratory medical visits for all ages and all medical facilities. 
The first step in BME is the creation of a prior probability distribution function (PDF) 
for each space-time point in the study area of Abu Dhabi. The prior PDF is created based on 
general knowledge. General knowledge refers primarily to a) the mean trend, or expected 
value, of the health data, and to b) the covariance between different space-time points. The 
mean trend is defined as  
mx(p)=E[X(p)] 
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and the covariance is defined as  
cx(p,p’)=E[(X(p)-mx(p)) (X(p’)-mx(p’))]. 
 
The prior PDF is defined by  
fG(χmap) = exp { µo+ µ1 g(χmap) +…+ µNcgNc(χmap) }, 
 
where µα represents the Lagrange coefficients, gα(χmap) is a function of the data representing 
general knowledge, and Nc represents the number of pieces of general knowledge available 
from the data. Because the process involves maximizing the amount of general knowledge 
available, this process can also be referred to as “maximum entropy”. 
The mean trend and the covariance model, crucial components of general knowledge, 
were carefully constructed from the Abu Dhabi health data available. The mean trend was 
assumed to change based on space-time location, that is, it was assumed that the expected 
rate of medical facility encounters differed based on location within the study area and time 
within the year.  
A covariance model with two nested structures was constructed, each structure being 
space/time separable. The covariance model defines the space-time variability in the data, 
and is a function solely of the distance in space and distance in time between space-time 
points:  
 
cX(p,p’) = cX((s,t), (s’,t’)) = cX( r=||s-s’|| , t=|t- t’|) 
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The distance in space between two rate measurements, ||s-s’||, is referred to as the 
spatial lag, r, and the distance in time between two measurements, |t - t’|, is the temporal lag, 
τ. For the Abu Dhabi rate of medical facility encounters, an exponential covariance model 
was adopted. The model consists of two nested, space-time separable structures; one 
structure accounts for long-term variation in covariance, while the other accounts for 
variations explicit for small changes in space and time. The model is shown here: 
 
cX(r, τ) = c01 exp[-(3r/ar1)] exp[-(3τ/at1)] + c02 exp[-(3r/ar2)] exp[-(3τ /at2)], 
 
where r is the spatial lag, τ is the temporal lag, c01 is the sill of the first nested covariance 
structure, c02 is the sill of the second nested covariance structure, ar1 is the spatial range of the 
first nested structure (and ar2 is the spatial range of the second), and at1 is the temporal range 
of the second nested structure (and at2 is the temporal range of the second). The term sill 
refers to the variance from the mean of the data. Since exp(-3) ≈ 0.05, the point at which the 
spatial lag, r, equals the spatial range, ari, is the distance where 95% of the spatial covariance 
has dissipated. The same relationship holds true for the temporal covariance component. This 
covariance model has been used widely in previous BME studies, and has been shown to fit 
data well (Christakos et al, 2005).  
Depending on the outcome of the analysis, different spatial and temporal ranges and 
sills were used. These parameters are specified in the results section, along with the 
accompanying covariance graph and estimation map. It is this general knowledge (the mean 
trend and the covariance model) that allow for the formation of the prior PDF. 
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The next stage, called the “meta prior”, organizes the site-specific knowledge, S, into 
hard and soft data points. This differentiation was described above, and each map in the 
results section is labeled with the type of data, hard or soft, used.  
The final “posterior” or “integration” stage, updates the prior PDF with site-specific 
knowledge, S, which yields the posterior PDF. The posterior PDF estimates a rate of medical 
facility encounters at close intervals along the study region. A process known as Bayesian 
conditionalisation achieves the desired posterior PDF from the integration of S with the prior 
PDF. The process was run so that each estimation borrows information from the 3 nearest 
soft interval data points. For a dataset composed of soft interval data, the following procedure 
is followed: 
Since xmap=(xhard, xsoft, xk), the posterior PDF is given by  
 
fK(χk) = A-1 dχ soft∫ fS (χ soft ) fG (χhard ,χ soft ,χk ) , where 
A=  dχk∫ dχ soft∫ fS (χ soft ) fG (χhard ,χ soft ,χk ) 
 
is the normalization constant. 
Based on the posterior PDF, a rate of medical facility encounters is estimated for each 
point of the study area, resulting in a smooth risk surface. 
 
6.3.2 Creating Maps from BME Output 
 
After completing the analysis, the final touch was the creation of presentable maps 
from the BME output. BME produces mapping results in a raster format and in a point file 
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format. The raster output can be displayed in ArcGIS, projected against the original study 
area boundaries. The raster is clipped to the extent of the geographic study area by setting an 
analysis mask to the study area and then applying the raster calculator to the raster file.  
Under the symbology tab, a classified color scheme was created in which the colors 
ran from ivory, to pale pink, to warm gold, to crimson, to onyx. Such a color scheme will 
print in black and white without losing the entire meaning the map presents in color. The 
scheme makes a clear distinction from lighter to darker colors as the map moves from areas 
of lower risk to areas of higher risk.  
 
6.3.3 Method 2: Waller Model through Bayesian Hierarchical Modeling 
 
Hierarchical modeling is the dominant method for creating disease maps. Its use was 
accelerated in the 1990s due to faster computational methods for estimating the posterior 
PDF through sampling. WinBUGS was used to implement these methods for the purpose of 
the analysis described here (BUGS stands for Bayesian modeling using Gibbs sampling; Win 
stands for its functionality under the Windows operating system). The use of WinBUGS for 
disease mapping is described in Andrew Lawson’s 2003 book, “Disease Mapping with 
WinBUGS and MlwiN”. A summary of the statistical theory behind the Bayesian 
hierarchical modeling approach is described here, as well as a brief description of the Waller 
Model used specifically for this stage of the study. 
Often, disease maps under the hierarchical modeling approach are a construct of the 
observed rate or count, yi, of disease in a tract and an expected rate or count, ei, of disease in 
a tract. The expected rate takes account, for example, of the underlying age or gender 
structure of a particular tract of the study area that might naturally precipitate a higher or 
 26
lower rate compared to the average. For example, the rate of certain cancers may be elevated 
in areas with an elderly population. Then, θi= yi/ei is the standardized morbidity/mortality 
ratio (SMR) for each tract.  
 In this study, SMRs were computed by first multiplying the monthly rate of medical 
visits across the entire study region by the population in each study tract, yielding an 
expected count for each study tract during each month of 2008. Observed counts per monthly 
tract were divided by the corresponding expected count. In equation form, this SMR 
computation looks like: 
 
Mapping SMRs produces a crude spatial depiction of disease risk that, as previously 
described, can prove inaccurate. For example, SMRs can vary drastically with even slight 
changes in expected risk. To avert such problems, SMRs can be incorporated into a model-
based approach complete with an accounting of random effects. Random effects are spatial 
variations in disease risk that caused by factors not accounted for by the predictor variables. 
These variations can be caused by 1) differences in an individual’s tendency to be afflicted 
by a disease; 2) inaccuracies in GPS coordinates specifying the location of disease incidence; 
and 3) other factors. Random effects can be modeled either as a global variable, affecting the 
entire study region similarly, or as local effects that give rise to disease clusters. Random 
effects may also be classified as either correlated heterogeneity, meaning that the disease rate 
in a particular tract is influenced by its neighbors, or as uncorrelated heterogeneity, meaning 
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the opposite. Correlation can indicate the presence of unobserved environmental effects. To 
impose a hierarchical structure on the random effects, a prior distribution is assigned to them. 
The parameters of the prior distribution are also assigned hyperprior distributions.  
 The Waller model is defined as  
 
yik ~ Poisson(eikθik), 
log θik =α + ui(k) + vi(k), 
 
where α is an overall level of the disease risk across the entire study region, ui(k) measures 
correlated random effects between tracts at different times, and vi(k) measures uncorrelated 
random effects. Thus, the α level of risk (which acts like an average starting point) is 
heightened or reduced based on the random effect terms for each location.  
 The variability of v and u are controlled by the parameters τ2v and τ2u, and each is 
defined by a hyperprior distribution (in this case, the gamma distribution is used). The 
statistical set-up creates the posterior PDF, from which estimation points on the smoothed 
disease map are extracted. WinBUGS uses Gibbs sampling (a type of Markov chain Monte 
Carlo simulation) to evaluate the posterior PDF.  
 
6.3.4 Creating Maps from Waller Model Output 
 
Hierarchical modeling, as implemented in WinBUGS, cannot function if point data 
are supplied. Instead, point data must be converted to disease rate estimates for polygons. We 
created polygons representing catchment areas for medical facilities using the method 
described under the Data Preparation section. A program called “maps2winbugs” can be 
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downloaded from the Internet. This program is a simple aid that rewrites the ArcGIS 
shapefile of the study area (in polygon form) as a S+ file that can be read by WinBUGS. The 
S+ file of the study area is embedded into WinBUGS by first opening WinBUGS, then 
opening the S+ file inside of WinBUGS, and finally using the GeoBUGS menu item to add 
the S+ map file into WinBUGS.  
 WinBUGS codes can be downloaded from http://www.sph.sc.edu/alawson/. Under 
the heading of “WinBUGS ODC files from the book Disease Mapping with WinBUGS 
and MLwiN”, the BYM code can be accessed by downloading the odc files marked as “data 
(chapter six)”. Within the resulting zip file is a file called “chapter 6.1.5 (normal)”, and this 
contains the code adapted for use in this study. The downloaded code came prepared with 
data pertaining to a study of Ohio respiratory rates, but was replaced with the UAE health 
data. For each polygon, the e=(…) field was replaced with observed counts, and the m=(…) 
field was replaced with the expected counts. Since the model cannot handle zero counts, a 
polygon with no observed encounters is replaced with a small number such as one. This 
maneuver was necessary for 40% of respiratory tracts, because many tracts have a very small 
population where no medical visits for the specified diseases occur for most months. The 
field signifying the total number of polygons was also changed from the original downloaded 
version to one reflecting the UAE health data. 
 The WinBUGS code contains the geographic data necessary for signifying which 
polygons neighbor each other (a key component of the Waller model). The three fields 
retaining this information are: Adjacency, SumNeigh, and Num. This information can be 
easily created through the kind provision of the Adjacency Tool for WinBUGS provided by 
the United States Geological Survey at the following site: 
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http://www.umesc.usgs.gov/management/dss/adjacency_tool.html. The tool may be freely 
downloaded and installed into ArcGIS, and comes with necessary instructions.  
 After loading the model and the data, 5,000 iterations were run as an initial burn-in 
period. The model was run for 15,000 further iterations to allow the model to reach 
convergence. “Mu” was the variable set to be modeled as map output under the “sample” 
monitor. Posterior mean estimates and error estimates were retrieved and entered into 
ArcGIS.  
 
 
6.3.5 Summary of BME and Waller Model Differences 
 
Some key differences between the two mapping approaches can be summed up as: 
1. The Waller model estimates disease risks by borrowing information from 
adjacent tracts, while the BME model borrows information from the closest site-
specific data (in this case, it was the three closest soft data points). 
2. The Waller model assigns hyperparameters to its prior model, whereas the 
BME model does not estimate the error associated with its prior. 
3. BME relies on point data, while the Waller model requires inputs by 
polygons, or tracts. 
7 Results  
 
7.1 Basic Statistics 
 
This analysis is based on medical facility visits in Abu Dhabi emirate only. Data was 
analyzed in terms of visits per 100,000-people. Since data was obtained from an insurance 
company representing 73% of the population in Abu Dhabi emirate, visits were multiplied by 
(100/73) in order to scale up to 100% of the population. Additional scaling up was required 
to account for the 16% of data discarded for lack of geographic information.  
Four main categories of disease, medical facilities, and age were used. The first two 
are all-inclusive: respiratory diseases, and cardiovascular diseases, for all demographic 
groups and for all medical facilities. The third consists of respiratory diseases for all medical 
facilities, but limited to children under age 15. The remaining group is composed of 
respiratory visits committed by those of all ages, but all pharmacy visits are removed.  
As previously defined, all hospitals, clinics, centers, pharmacies and other treatment 
sites of medical distress, for which geographic information was available, are included as 
‘medical facilities’. Respiratory diseases refer to pneumonia (480-486), asthma (493), 
chronic pulmonary obstructive diseases (490-492, 494-496), and pneumonitis (507), where 
each disease is coupled with its ICD-9 code. Cardiovascular diseases are those under the 
following ICD-9 codes: 390-448.  
Table 2 summarizes some very basic statistics regarding these medical visits.  
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Health Outcome  Population 
in Abu 
Dhabi 
Emirate2 
Total Counts3 
(scaled up to 
account for 
incomplete 
and loss of 
information) 
Rate (Total 
Counts/ 
Population) 
Counts (in 
Visits/100,000) 
Respiratory 
diseases, all ages 
1,600,544 35,982 0.02248 1,888 
Cardiovascular 
diseases, all ages 
1,600,544 74,392 0.04648 3,904 
Respiratory 
diseases, children 
under 15 
239,566 13,664 0.05704 4,791 
Respiratory 
diseases, all ages, 
no pharmacies 
1,600,544 30,644 0.01915 1,915 
Table 2. Summary of basic statistics gleaned from study data, including all months, January through 
December, in 2008. 
 
Counts of medical visits vary widely with month. Counts are highest during the 
summer months, and lowest in the winter. The dramatic dearth of visits in November and 
December suggests that data was not fully reported for these months. Raw counts per month 
are summarized in Table 3.  
 
                                                 
2Population data, for the entire emirate and for children, is pulled from the Abu Dhabi Health 
Statistics 2008 report. 
3All health data was received from Dr. Jens Thomsen and Mr. Mohammed Al-Jadaa of 
HAAD, with help from other HAAD officials 
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Month Raw Visits 
Counts, 
Respiratory  
Raw Visits 
Counts, CVD 
Raw Visits 
Counts, 
respiratory, 
under 15 years 
Raw Visits 
Counts, 
respiratory, no 
pharmacy visits 
January 93 112 34 65 
February 142 337 66 104 
March 433 866 152 315 
April 1,105 1,926 447 772 
May 4,255 8,390 1,758 2,788 
June 5,377 13,147 1,679 3,312 
July 5,374 11,382 1,348 3,365 
August 4,977 12,982 1,732 3,193 
September 4,977 8,985 2,444 3,027 
October 3,438 4,305 1,819 1,833 
November, 
December 53 56 N/A 17 
Table 3. Monthly progression of raw disease counts. Not enough data is available to record December as 
a separate month. Data for November was either not sufficient or available for respiratory visits amongst 
children under 15.  
 
7.2 Comparison of Statistics Retrieved from HAAD Data with Other Statistics 
Published by the UAE 
 
 In order to verify the data, these counts and rates calculated above were compared to 
basic health statistical information from health agencies in the UAE. General health statistics 
for the specified diseases were not available from individual emirates’ health agencies 
(including Abu Dhabi’s), but some information was available from the Ministry of Health.  
The Ministry of Health publishes summary health statistics yearly. Often, the data is 
disaggregated by medical district. Each emirate (Abu Dhabi, Dubai, Fujairah, Sharjah, 
Ajman, Um Al Quwain, Ras Al Khaimah) constitutes its own medical district, with a further 
disaggregation for Abu Dhabi into three distinct regions (Abu Dhabi island, Al Ain and other 
eastern regions of the emirate, and the western regions). The statistics published include 
counts of live and still births, deaths by cause, and population estimates. Counts of doctors, 
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nurses, and medical technicians are available by medical district, as are counts of total 
visitations to each primary health care center.  
For the purposes of comparison with this study, the most relevant information from 
the Ministry of Health includes the total number of visits added up from all primary health 
care centers, per medical district, disaggregated by the disease for which treatment was 
sought. Unfortunately, Abu Dhabi data is excluded from these tables. Thus, the best available 
option is to compare 1) counts taken from the Abu Dhabi data used in this study (visits to all 
medical facilities per 100,000 people) to 2) the Ministry of Health data for all other emirates 
(visits to primary health care centers only, and not counting pharmacies or hospitals).  
 
 
 
Disease for which 
treatment was 
sought 
Respiratory Diseases Cardiovascular Diseases 
Abu Dhabi 
HAAD Data– 
asthma 
UAE Ministry of 
Health data 
(remaining 6 
emirates) – asthma, 
other diseases of 
respiratory system 
Abu Dhabi 
HAAD Data – all 
heart disease, 
hypertension 
UAE Ministry of 
Health data 
(remaining 6 
emirates) – all heart 
disease, 
hypertension 
Total Counts  17,558 41,804 42379 84,658 
Counts (in terms of 
visits/100,000) 
1,789 1,396 4,317 2,827 
Table 4. Comparison of similar diseases between HAAD study data and Ministry of Health publicly 
available data. Counts for the HAAD data have been scaled up by (100/73) and (100/84). HAAD counts 
increase by 128% for respiratory diseases, and 153% for cardiovascular diseases.  
 
In light of the broader catchment of medical facilities that fall into the Abu Dhabi 
HAAD data, the higher counts per 100,000 in favor of the HAAD data that Table 4 
summarizes might be expected, for both respiratory and cardiovascular diseases. Thus, it 
appears that the data used in this study is in general agreement with other indicators 
published by the UAE.  
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7.3 Comparison of Statistics Retrieved from HAAD Data with Other Statistics 
Published by Other Countries 
 
 The research data was further compared to similar indicators from other countries 
with reliable health records. These are summarized in Table 5.  
 
Disease Estimated Counts per 100,000 
HAAD data, asthma medical visits, all 
ages 
1,789 
HAAD data, asthma medical visits, ages 
6-12 
1811 
USA, asthma, all ages4 7,669 
USA, asthma, all ages5 7,000 
Qatar, ‘asthmatic children’ aged 6-126 19,800 
Qatar, ‘children with asthma or 
wheezing’, aged 6-127 
10,400 
World-wide prevalence of asthma8,9 4,480 
Table 5. Statistics on various asthma medical visits from various counties and various sources. Although 
HAAD data describes a different health outcome than other measures, it appears that study data either 
underestimates asthma medical visits, or that asthma rates are lower in Abu Dhabi than other countries. 
In light of higher measures from neighboring countries, it appears that the latter is not the case.  
 
                                                 
4
 Centers for Disease Control and Prevention (2008), and the US Census Bureau, Population 
Division (2008) 
5Fanta, C. (2009). Review article: Asthma. New England Journal of Medicine, 360(10), 
1002-1014. 
6Bener, A., Kamal, M., & Shanks, N. (2007). Impact of Asthma and Air Pollution on School 
Attendance of Primary School Children: Are They at Increased Risk of School Absenteeism? 
Journal of Asthma, 44(4), 249-252. 
7Bener, A., Kamal, M., & Shanks, N. (2007). Impact of Asthma and Air Pollution on School 
Attendance of Primary School Children: Are They at Increased Risk of School Absenteeism? 
Journal of Asthma, 44(4), 249-252. 
8World Bank, World Development Indicators 
9Fanta, C. (2009). Review article: Asthma. New England Journal of Medicine, 360(10), 
1002-1014. 
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 It is not possible to put full faith in a comparison between statistics from other 
countries with the Abu Dhabi HAAD study data. As previously mentioned, study data is in 
terms of medical visits, while the corresponding numbers from other countries are in terms of 
numbers of individuals stricken with the disease. It may be expected that medical visits 
exceed numbers of stricken individuals with the disease, since a single person with asthma 
may make multiple hospital visits. However, the opposite is true here; the study data of 
medical visits actually is at a lower rate. This low number of visits might suggest that the 
Abu Dhabi HAAD study data slightly underestimates the true risk of respiratory diseases. 
The lower counts might be due to the presence of a lower disease risk in the UAE, 
circumstances related to the data collection process, or individuals not seeking medical 
attention while under respiratory distress. Another explanation is that the UAE simply has a 
lower prevalence of respiratory diseases than the world-wide average would indicate, 
although published research in the area reporting comparable asthma rates to those in the 
United State and Europe seem to refute this suggestion.  
 
7.4 Comparison of Frequencies of Counts Under the Four Data Categories 
 
For each category of data, a histogram of the frequency of medical visits per month, 
normalized to a year, was produced. Again, all data pertains only to medical visits within 
Abu Dhabi emirate. The monthly counts were normalized to a year prior to creating the 
histograms and proceeding with the remaining analysis and disease map creation. Since the 
raw histograms have a pronounced right skew, the data was log-transformed (using a natural 
log operator) prior to its use in creating disease maps. Log-transforming the data produced a 
nice, normal histogram. 
 The high number of ‘0’ frequencies on the histograms affirms the very low 
 36
population density across much of the geographic space in Abu Dhabi. Most of the 
population is clustered in cities, meaning that the relatively paucity in population numbers in 
the majority of space-time tracts is ill-suited for producing a constant stream of medical visit 
records. 
 Comparing histograms between data categories indicates that cardiovascular diseases 
occur with more frequency than respiratory diseases. This visual indication is affirmed by the 
aggregate counts: while the raw count of respiratory disease visits considered added up to 
just under 20,000, cardiovascular diseases (CVD) exceeded 40,000 (before the data was 
scaled up to account for incomplete information and loss of information). CVD is also the 
most common chronic disease in adults, and adult males compose the largest proportion of 
the population, explaining these counts. Although limiting the respiratory scenario to 
children reasonably garners fewer counts, it will be shown later that rates of respiratory 
diseases among children are predicted to be higher. Selected histograms can be found below, 
and the entire set of raw and log-transformed histograms can be found in Appendix 2: 
Histograms.   
 
 
 
Figure 4. Raw histogram of respiratory medical visits. 
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Figure 5. Log-transformed histogram of respiratory medical visits. The values to the left are due to zero 
counts in space-time tracts. When a count of zero is converted into interval soft data, the lower bound 
will be negative. Since health risks are assumed here to be non-negative, the lower bound is then 
truncated at zero. This truncation causes the mean of the soft data interval to be artificially high (it ought 
to be at zero). The values to the left are the distribution of means of soft data zero counts after truncation.  
 
Figure 6. Raw histogram of cardiovascular medical visits. 
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Figure 7. Raw histogram of respiratory medical visits in children under 15. 
 
7.5 Mean Trend and Covariance Models for the Four Data Categories 
 
As described in the methods section, two pieces of general knowledge are necessary: 
the mean trend and the covariance. The temporal mean trend adopted for this study 
represents an intermediate stage between 1) capturing the full mean trend, and 2) assuming 
the mean trend is constant. The adopted mean trend for respiratory diseases is shown in 
Figure 8. For a sensitivity analysis of other temporal mean trends possible, and their effect 
on spatial covariance, please see Appendix 3: BME Mean Trends and Covariance 
Models.  
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Figure 8. A sample intermediate temporal mean trend assumption, a requisite piece of general knowledge 
off of which the remaining analysis is based. The dotted line is the actual progression of the data points, 
and the solid line is the assumed mean trend. 
 
 In order to adopt any particular spatial or temporal mean trend, smoothing parameters 
must be specified and these determine the degree of constancy the mean trend exhibits. The 
temporal smoothing range is the length of time over which a mean value (in this case medical 
visits) should be taken, while the search radius refers to an upper limit of information 
computed simultaneously. A corresponding set of spatial parameters defines the equivalent 
over a distance in space. The mean trend smoothing parameters used in the study are 
summarized in Appendix 3: BME Mean Trends and Covariance Models.  
Covariance, or the numerical measure of how two data points change with each other 
over space or time, is a key component of the BME model, specifically in forming the prior 
PDF. Each category of data was fitted to a unique covariance model that measures the 
covariance between points that are successively further apart from each other, whether in 
space or in time. Thus, the spatial covariance graphs are measured by distance (in 
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latitude/longitude degrees) on the x-axis, while temporal covariance graphs are measured by 
days.  
Spatial covariance was sought for at different temporal aggregations. Very little 
spatial covariance existed at a one-year aggregation scheme. However, spatial covariance 
emerged when the time aggregation period was shortened, whether at 3 months, 1 month, or 
shorter, indicating that a space-time interaction term exists. The study focuses primarily on 
monthly rates. Sample spatial and temporal covariance plots that were adopted for this study 
are shown in Figures 9-10, for respiratory medical visits in all ages; the full set of plots 
adopted for remaining disease categories are encapsulated in Appendix 3: BME Mean 
Trends and Covariance Models. The plots show that as distance between medical facilities, 
the covariance of their visitation rates falls (as one would expect). The figure here shows that 
at a distance of approximately 50 kilometers, any spatial covariance of visitation for medical 
facilities with such a distant breach has all but vanished. 
 
 
Figure 9. Spatial covariance of respiratory medical visits per 100,000 people; values log-transformed. 
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Figure 10. Temporal covariance of respiratory medical visits per 100,000 people; values log-transformed. 
 
  
 Each covariance model is fitted with an estimated covariance plot, represented by the 
blue line. These models all consist of two nested, space-time separable models, and are given 
in the following table.  
 
Category of Data Covariance Model 
General covariance 
model 
cX(r, τ) = c01 exp[-(3r/ar1)] exp[-(3τ/at1)] + c02 exp[-(3r/ar2)] exp[-
(3τ /at2)2] 
Respiratory diseases, 
all ages 
cX(r, τ) = 7.1 exp[-(3r/0.35)] exp[-(3τ/89)] + 2.9 exp[-(3r/9)] 
exp[-(3τ /90)2] 
Cardiovascular 
diseases, all ages 
cX(r, τ) = 7.3 exp[-(3r/0.45)] exp[-(3τ/99)] + 3.2 exp[-(3r/15)] 
exp[-(3τ /100)2]  
Respiratory diseases, 
children under 15 
cX(r, τ) = 6.0 exp[-(3r/0.4)] exp[-(3τ/125)] + 3.5 exp[-(3r/0.7)] 
exp[-(3τ /160)2]  
Respiratory diseases, 
all ages, no 
pharmacies 
cX(r, τ) = 7.1 exp[-(3r/0.3)] exp[-(3τ/99)] + 3 exp[-(3r/7)] exp[-
(3τ /100)2] 
Table 6. Covariance models, where r is the spatial lag, τ is the temporal lag, ar is the spatial range, and at 
is the temporal range. The lags specify the distance between the two space-time points whose covariance 
is measured, and the ranges indicate the distance at which 95% of the covariance between points at the 
same location has dissipated. A more complete description of the parameters of these equations are 
explained under the methods section. 
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 An interesting feature of most of these spatial covariance plots is that they, unlike 
their temporal counterparts, do not all fall to zero after a reasonable interval of distance. It is 
expected that separate points at a distance of two or three geographical degrees (equivalent to 
200-300 kilometers) would no longer have a correlated health risk, indeed, that the health 
risk covariance ought to fall to zero. This expectation occurs only for the case of respiratory 
medical visits in children. A plausible explanation for this occurrence may be that due to the 
flat and homogeneous landscape characterizing much of the UAE (expect for cities), the 
health risks stay fairly constant over a long distance. On the other hand, areas inhabited by 
children are for the most part limited to cities. The non-homogeneous nature of child 
dwelling-spots may explain why spatial covariance does drop to zero when modeled for a 
dataset consisting of children only.  
 
7.6 Maps of Estimated Rates Over Time, BME 
 
 
 As the temporal mean trend figures have heretofore shown, along with the table of 
counts by month, the number of respiratory and cardiovascular complaints rise dramatically 
during the summer months. Here follows a progression of selected maps over time that points 
to the increase of health risks as the middle of the year approaches. First are shown maps of 
respiratory medical visits, then cardiovascular diseases, next respiratory diseases of those 
under age 15, and finally respiratory medical visits excluding pharmacies.  All maps are 
included in Appendix 5: Estimation Maps, BME.  
 43
 
Figure 11. Incidence rate of respiratory medical visits, February, April, June, August, September, and 
November 2008. (Visits per 100,000 people per year). Roads are shown as black lines. Rates are log-
linearly distributed between the lower and upper bounds.  
Figure 11 shows respiratory spatial maps from months selected throughout the year. 
The maps agree with the general time trend graph, showing higher rates of visits during 
summer months. They also show a shift in disease high-risk spots moving across the country 
from west to east.  
 The figures below show a single map from the remaining categories (CVD, 
respiratory under 15 years, respiratory without pharmacies) for comparison purposes. Both 
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cardiovascular diseases and respiratory diseases in children under age 15 pose higher rates 
than respiratory disease medical visits in all ages.  
 
Figure 12. August, 2008 incidence rate of cardiovascular medical visits. (Visits per 100,000 people per 
year). Rates are log-linearly distributed between the lower and upper bounds. Roads are shown as black 
lines. CVD disease rates appear to be higher than respiratory rates for the same month, as expected 
based on the higher counts of CVD hospital visits in the original data.  
 
 
Figure 13. August, 2008 incidence rate of respiratory medical visits amongst children. (Visits per 100,000 
children per year). Roads are shown as black lines. Rates are log-linearly distributed between the lower 
and upper bounds. Children appear to experience a higher rate of respiratory morbidity, but their rates 
are also confined to different sections of the country, compared to other disease categories (likely because 
working adults, especially foreign laborers, often work in rural, industrial areas without many children).  
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Figure 14. August, 2008 incidence rate of respiratory medical visits, excluding visits at pharmacies. 
(Visits per 100,000 people per year). Roads are shown as black lines. Rates are log-linearly distributed 
between the lower and upper bounds. This map differs quite dramatically from that of respiratory rates 
including all medical facilities visited.  
 
Looking at maps of different categories for the month of August, it appears that 
respiratory and cardiovascular disease risks occur hand-in-hand in most areas, with small 
variations. Respiratory disease risk in children is markedly different in its spatial aspect 
compared to respiratory disk amongst all people, in part because few children live in the 
rural, industrial area central to the Emirate (mainly inhabited by adults working as laborers). 
Rates among children are also higher, and respiratory diseases such as asthma are more 
common among children.  
In addition, the respiratory visit rates that exclude pharmacies are approximately one 
third lower than visits boasted at the entire pool of medical facilities (the highest rate drops 
from 9300 visits/100,000 people/year to 6100 visits/100,000 people/year). Pharmacy visits 
may be due to medicine refills, or may be follow-ups to doctor visits. The maps that exclude 
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pharmacy visits (see Appendix 5: Estimation Maps, BME for further samples) show rates 
tilted toward the maximum more widespread throughout the entire study region.   
 
7.6.1 Variance Error Maps, BME 
 
 As with all statistical analyses, the estimated values must come with an error variance 
measure. These areas can be displayed on a map. As expected, those areas with low error 
variance values are those with high population densities. The error variance maps are nearly 
identical in appearance across all data categories, and a sample (from respiratory data from 
all ages) is shown here.  
 
Figure 15. Error variance map for respiratory diseases. Areas with a high population density have a 
lower variance, and thus, more faith can be placed in those estimates. 
7.7 Maps of Estimated Rates Over Time: Waller Model Maps 
 
Selected maps underpinned by the Waller model are shown here (refer to Appendix 
6: Waller Estimation Maps to view all Waller model maps). These maps (of respiratory 
diseases) exhibited no west to east progression of health risk hotspots over time, although 
they did in general appear to light up at the same areas as BME maps.  
 47
 
 
Figure 16. Incidence rate of respiratory medical visits from Waller model output, February, April, 
August, and November 2008. (Visits per 100,000 people per year). Roads are shown as black lines.  
7.7.1 Tracts with the Consistently Highest Respiratory Medical Visit Rates, Waller 
Model 
 
For each month, it was possible to identify the tracts that the Waller model 
recognized as having the highest rates of respiratory diseases. One tract, located in Abu 
Dhabi, had rates that ranked in the top ten for each of the ten months (February to 
November), shown in Figure 17. Tracts that ranked among the top ten rates for at least five 
months include areas in Al Ain and industrial regions in the center of the emirate. These 
tracts are highlighted in Figure 18.    
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A more nuanced ranking of the tracts with the highest rates would take into account 
the number of medical facilities per each tract. The tracts highlighted here may appear to 
have higher rates by virtue of the medical establishments they house, although this was not 
examined.  
 
Figure 17. A single tract in Abu Dhabi has among the ten highest rates of respiratory medical visits for 
the entire period examined, according to Waller model output. 
 
Figure 18. Tracts with among the highest rates for at least five months are dispersed in Abu Dhabi, Al Ain, and 
industrial regions, according to the Waller model output.  
7.7.2 Maps of Standard Deviation, Waller Model 
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 Waller model estimates of health risk are accompanied by the standard deviation of 
the posterior PDF of those estimates. The standard deviation is a measure of error, and equals 
the square root of the variance error values provided in the BME analysis. The standard error 
map for respiratory health risks in August, 2008, is provided in Figure 19. Quite in contrast 
to the BME map of error, here error appears to be the highest in tracts where population 
density, and medical visits, were the highest. The Poisson distribution, on which the Waller 
model is based, gives higher variances where the estimate (in this case, the estimated rates, 
are higher).  
 
Figure 19. Map of standard deviations of the Waller model estimates of health risks, for August, 2008.  
7.8 Statistical Comparison between BME Output and Waller Model Output 
 
7.8.1 Differences in Estimates of Health Risks 
 
In order to compare BME maps with Waller model maps, several scatterplots were 
created to gauge the level of correlation between the estimates provided by each model. The 
model outputs were also compared to the crude rates per tracts. In other words, the variables 
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in the scatterplots include: the posterior mean estimate per space-time tract for Waller model 
maps; the average posterior mean estimate per space-time tract for BME model maps; and 
the crude prior mean estimate per space-time tract. Data from all space-time tracts were used. 
The scatterplots between these variables are shown below, along with a table of correlation 
coefficients. 
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Figure 20. Scatterplot of BME estimated values and crude values, for respiratory medical visits. The log-
transform of the BME values has been removed. The correlation coefficient between these two variables 
is 0.4428. 
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Figure 21. Scatterplot of Waller model estimated values and crude values. The correlation coefficient 
between these two variables is 0.5957.  
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Figure 22. Scatterplot of Waller model estimated values and BME estimated values. The correlation 
coefficient between these two variables is 0.2547. 
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Correlation 
coefficients 
Crude values BME estimates Waller model 
estimates 
Crude Values 1.000 0.4428 0.5957 
BME estimates -- 1.000 0.2547 
Waller model 
estimates 
-- -- 1.000 
Table 7. Correlation coefficients between disease risk values derived from a crude map and two 
estimation maps produced from different methods. 
 As evidenced by the correlations, the BME and Waller model maps are not in cordial 
agreement with one another, with BME output consistently producing smaller estimates. In 
addition, BME estimates are in general agreement with crude rates; the correlation 
coefficient of 0.4428 allows general crude trends to prevail in the estimated output, while 
permitting a good amount of smoothing. Of note are the units on the axes of the BME/Crude 
scatterplot; the highest crude rates are about seven times as large as the highest BME 
estimates (35,000 visits/100,000 versus 5,000 visits/100,000). However, only a sprinkling of 
crude rates extends so far; the overwhelming majority of crude rates and BME estimated 
rates are in the same neighborhood of each other. 
Since tracts with a disease risk of zero are common, these were removed to test 
whether doing so improved agreement between BME estimates and crude estimates. This 
maneuver produced little effect except to decrease the correlation to 0.3318. Since large 
populations produce more dependable rates, a second variation was performed that included 
only tracts with populations above 4,000. Again, correlation changed but slightly, falling a 
tremble to 0.4333. 
The Waller output faired slightly higher in its correlation to crude rates, at 0.5957. 
Exclusion of tracts with zero crude counts contracts the correlation by an eyelash, to 0.5757. 
Allowing only those tracts with a population of at least 4,000 accrued an improvement in the 
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correlation coefficient, to 0.6124. The closer agreement of Waller model output to crude 
rates, as compared to BME output, may be a consequence of several factors.  
First, the lower correlation signifies that BME has potentially wielded a greater 
smoothing power. Under BME, a high crude rate is dampened while a low rate is pulled 
upwards. This strong smoothing action may be due to parameters set during the modeling 
process. First, the temporal mean trend assumed for BME, while not set to be constant, was 
substantially relieved of its true alpine ascent during the summer months. Referring to the 
temporal mean trend shown earlier in Figure 8 (and in Appendix 3: BME Mean Trends 
and Covariance Models), the difference between the actual mean trend and the assumed 
mean trend certainly may be responsible for the strongly smoothed BME results. More 
research can examine whether BME output smoothes all rates proportionally, or if certain 
rates defined by singular characteristics (such as population size and visit counts) are affected 
more. 
Second, a portion of BME’s presumed smoothing power may be artificially induced 
because of the nature of BME output. BME estimates are given as a multitude of rates within 
each tract, rates which are then averaged inside that space-time tract in order to compare 
them with the single value per tract provided in the crude and Waller model maps. Perhaps 
this averaging operation undermines both high rates and low rates within the same tract, so 
that the nuances are lost and the averaged result is distorted from clarity and agreement with 
other measures.  
It might be convenient to suggest that the soft data set-up of the BME model further 
dampened agreement with observed rates. As described in the methods section, BME input 
data was distinguished by a lower and upper bound (calculated by adding or subtracting 
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0.5/population for each tract). Under this framework, estimates adjoining the observed rate 
need not match the actual observation; the estimates may elope from the observation so long 
as they stay within the lower and upper bounds prescribed. A tract with a small population 
could allow for estimates that are greatly removed from the crude data. However, since 
restricting the calculation of crude/BME correlation to tracts with large populations produced 
a lower coefficient, this explanation is weakened.  
7.8.2 Differences in Error Estimates  
 
A small analysis was performed on the error distributions of the Waller and BME 
models. The error distributions have a comparable right skew, especially after the log-
transform is removed from the BME values. Waller model error distributions are closer to 
zero. Thus, Waller model maps have a smaller spread. 
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Figure 23. Histogram of errors of BME estimates, log-transformed. 
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Figure 24. Histogram of errors of BME estimates, log-transform removed. 
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Figure 25. Histogram of errors of Waller model estimates. 
 
7.9 Health Risks and Potential Contributing Factors 
 
 
7.9.1 Temperature and Time of Year 
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Health risks are increased during the warmer months, suggesting that the heat and/or 
humidity and increased morbidity are linked. The crude correlation is estimated to be 0.9421 
between average monthly temperatures and number of respiratory medical visits. Refer to 
Figure 26. This finding agrees well with one of the few in-depth studies on the link between 
high temperatures and respiratory and cardiovascular disease hospital admissions (Lin, 
2009). This study found that extremely high temperatures that exceeded 36°C (or 96.8°F, 
which is relatively mild during the UAE summer) resulted in increased admissions in New 
York City.  
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Figure 26. Correlation between health risk and monthly temperature.  
7.9.2 Air Pollution 
 
In addition, previous studies have provided strong evidence that air pollution affects 
respiratory and cardiovascular diseases. For comparison purposes to the health estimation 
maps shown previously, Figure 27 shows a map of estimates of particulate matter (PM10) in 
the air for August, 2008, juxtaposed next to a respiratory health risk map of the same period. 
It appears that some areas of highest estimated PM10 concentrations align with some regions 
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of highest health risks, although statistical tests are needed to prove a spatial correlation. A 
time series of predicted mortality attributable to PM10 for all of 2007 shows a comparable 
annual up- and down-swing inherent to the HAAD 2008 morbidity data (Figure 28).  
 
 
Figure 27. PM10 concentration map for the UAE, estimated on August 12, 2008, and the accompanying 
health risk map for August, 2008 (respiratory medical visits per 100,000).  
 
Figure 28. Estimates of daily mortalities believed caused by short-term exposure to outdoor PM10 in the 
UAE (January 1, 2007, – December 31, 2007). Figure is from the UAE 2010 State of Environmental Health 
Report.  
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Some maps are provided here that overlay sources of air pollution with the 
respiratory medical visit map for August, 2008. If air pollution is indeed partially behind 
elevated risk in some parts of the study area, then the sources of air pollution should be 
located in the same general areas. The maps of population centers and roads, both of 
which are venues of pollution emissions and shown in Figure 29, show this to be the 
case.  
 
Figure 29. Roadways and population centers laid over August respiratory medical visit rates, estimated 
with BME. Areas with an extensive network of roads and a high population are often, though not always, 
those with elevated health risks.  
8 Conclusions 
 
This study compared two separate mapping functions applied to UAE health data. The 
BME method begins with a prior probability function based on spatial and temporal 
covariance between data points. This prior is updated with site-specific data. The Waller 
model is based on a comparable idea, except that the parameters of the prior distribution are 
assumed to be uncertain, and thus are also set to probability distributions, proprietaries of 
their own hyperparameters.  
BME was found to be a stronger smoother than the Waller model, although this result is 
suspect since BME output was not in an ideal form for comparison with either crude rates or 
Waller estimates per space-time tracts. More rigorous comparisons should be done between 
BME and Waller models to figure out exactly which does what best. 
The high correlation between health risks and higher temperatures, which was surely 
already recorded at least anecdotally in the UAE, confirms what recent research has 
documented. Further research can also look into associations between respiratory and 
cardiovascular health outcomes and the air pollutant mixtures specific to the UAE. If firm 
links are established, then steps can be taken to mitigate inflammatory environmental 
contaminants causing health distress.  
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Appendices 
 Appendix 1: Data Categories and ICD-9 Codes 
 
 Analyses were performed and maps produced for the following four categories: 
1) Respiratory medical visits, all ages, all medical facilities 
2) Cardiovascular medical visits, all ages, all medical facilities 
3) Respiratory medical visits, children under age 15, all medical facilities 
4) Respiratory medical visits, all ages, all medical facilities except for pharmacies 
 
All diseases included in the study were identified by their code per the International 
Classification of Disease, Ninth Edition Respiratory ICD. Codes include: 
1) cardiovascular diseases (390-448), 
2) pneumonia (480-486), 
3) asthma (493), 
4) chronic pulmonary obstructive diseases (490-492, 494-496), and 
5) pneumonitis (507).  
 
 
 61
Appendix 2: Histograms 
 
Figure 30. Raw histogram of respiratory medical visits. 
 
 
Figure 31. Log-transformed histogram of respiratory medical visits. The values to the left are due to zero 
counts in space-time tracts. When a count of zero is converted into interval soft data, the lower bound 
will be negative. Since health risks are assumed here to be non-negative, the lower bound is then 
truncated at zero. This truncation causes the mean of the soft data interval to be artificially high (it ought 
to be at zero). The values to the left are the distribution of means of soft data zero counts after truncation.  
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Figure 32. Raw histogram of cardiovascular medical visits. 
 
Figure 33. Log-transformed histogram of cardiovascular medical visits. 
 
Figure 34. Raw histogram of respiratory medical visits among children under age 15. 
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Figure 35. Log-transformed histogram of respiratory medical visits among children under age 15. 
 
Figure 36. Raw histogram of respiratory medical visits, excluding pharmacies. 
 
Figure 37. Log-transformed histogram of respiratory medical visits, excluding pharmacies. 
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Appendix 3: BME Mean Trends and Covariance Models 
 
Part 1: Sensitivity Analysis Regarding the Influence of Temporal Mean Trends on 
Spatial Covariance Models.  
 
Here is described a sensitivity analysis performed on the spatial covariance function, 
which served as the prior model for the BME approach.  
 The form of the covariance plot depends on the mean trend assumption and the 
smoothing parameters that are first fed into the knowledge base. Interestingly, the spatial 
mean trend assumption has no effect on the form of the spatial covariance plot, but the 
temporal mean trend assumption does. The temporal mean trend can be modeled according 
to two extremes, as shown below. Each extreme produces a different spatial covariance 
model, one of which does settle to zero. The temporal mean trend assumption ultimately 
decided upon, also shown below, was a moderation of both extremes (it is this middle ground 
that can be found in the main body of this thesis). 
 The first extreme regarding the mean trend is to assume it is constant for all spaces 
and all times (Figure 38). Under this assumption, health risks over spatial distances are even 
more highly correlated than in the covariance figures shown previously. A corresponding 
sample spatial covariance plot, with the mean trend assumed constant, is presented in Figure 
39, although the general form holds true for all four data categories. This particular spatial 
covariance plot stabilizes at a relatively high level, after the initial drop. However, none of 
the evident temporal pattern over time is captured.  
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Figure 38. A constant temporal mean trend (for respiratory medical visit rates). Although the observed 
rates rise in the middle months (dotted line), the assumption fed into the model is that no changes in the 
mean over time occur (solid line). 
 
Figure 39. A spatial covariance model with a constant mean trend. The sill, or variance, is higher 
compared to the spatial covariance model actually adopted for the study, and the plot stabilizes at a 
higher level. However, no temporal changes are captured in this model.  
 
 
 The opposite extreme is to model the temporal mean trend so that it nearly precisely 
follows the actual temporal trend of the data. An example of what this looks like is shown in 
Figure 40. Of course, such a temporal mean trend assumption has consequences for the 
spatial covariance plot (keep reading). 
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Figure 40. A temporal mean trend fully modeled. The dotted line is the actual progression of the data 
points, and the solid line is the assumed mean trend. The assumed mean trend is modeled to be very close 
to the actual progression, and this has consequences for the spatial covariance model.  
  
  When the temporal mean trend is fully modeled, the sill of the spatial covariance of 
health risks is relatively low compared to the other scenarios, and quickly drops to zero. In 
fact, none of the other spatial covariance models actually tail out at zero, as this one does (see 
Figure 41). However, a covariance model that plunges almost directly to zero is problematic; 
it indicates that the covariance is too low with which to make a reliable map.  
 
Figure 41. Sample spatial covariance plot for a temporal mean trend that is fully modeled. In this case, 
the sill, or variance, is lower, but the covariance drops to zero rapidly. Such a model is not a good 
candidate for disease mapping.  
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These two extreme cases indicate that the temporal mean trend assumption affects the 
spatial covariance models. However, although the sills, spatial ranges, and other covariance 
models may shift, the covariance plot retains it same basic shape, regardless of mean trend. 
The peaks and valleys remain in the same positions.  
 The maps presented in the text of the main body, and in Appendix 5: Estimation 
Maps, BME, are based on a spatial covariance plot shown in Figure 43 (repeated here from 
its inclusion in the main text). This covariance plot is based on an intermediate temporal 
mean trend assumption, where it is not fully constant, but neither adheres so severely to the 
trend of the actual data (see Figure 42). Such a mean trend captures as much of the temporal 
variation as possible while still preserving the covariance necessary for the credence of the 
estimation maps.  
 
Figure 42. A sample (respiratory medical visit rates) intermediate temporal mean trend assumption, off 
of which the presented maps are based. The dotted line is the actual progression of the data points, and 
the solid line is the assumed mean trend. 
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Figure 43. Spatial covariance of respiratory medical visit rates, based on a pasteurized version of the 
temporal mean trend assumption that captures some, but not all, changes in medical visit rates over time. 
This plot is typical of those used to produce maps for the four data categories. 
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Part 2: All Temporal Mean Trend Assumptions Used 
 
 This section includes figures of all temporal mean trend assumptions used for each 
data category in the study. Also included are the smoothing parameters that determine the 
temporal mean trend (spatial smoothing parameters are also included, although the default 
was routinely accepted as these parameters were not found to affect the covariance plots).  
 As described in the main text, the temporal smoothing range (parameter #1) is the 
length of time over which a mean value should be taken, while the search radius (parameter 
#2) refers to an upper limit of information that can be computed simultaneously. A 
corresponding set of spatial parameters defines the equivalent over a distance in space. 
 Mean trend parameters are summarized in Table 8.  
 
Smoothing 
parameter 
Respiratory  Cardiovascular Respiratory, 
children 
Respiratory, no 
pharmacies 
Spatial search 
radius (Degrees) 
1.4526 1.4526 1.4526 1.4526 
Spatial smoothing 
range (Degrees) 
0.4842 0.4842 0.4842 0.4842 
Temporal search 
radius (Days) 
190 360 750 190 
Temporal 
smoothing range 
(Days) 
145 120 250 145 
Table 8. Spatial and temporal smoothing parameters used for each data category in the study. The spatial 
parameters are identical for each category because the default values proposed by the BME software 
were adopted. The spatial mean trend had no effect on spatial covariance. Temporal smoothing 
parameters differ based on data category, and these differences are realized in the shape of the temporal 
mean trends.  
 
 71
 
Figure 44. Mean trend assumed for respiratory medical visit rates, all ages. Dotted line illustrates the 
true temporal pattern, while the solid line indicates the assumed mean trend.  
 
 
Figure 45. Mean trend assumed for cardiovascular medical visit rates, all ages. Dotted line illustrates the 
true temporal pattern, while the solid line indicates the assumed mean trend. 
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Figure 46. Mean trend assumed for respiratory medical visit rates, in children under age 15 only. Dotted 
line illustrates the true temporal pattern, while the solid line indicates the assumed mean trend. This 
mean trend is the most unusual of all the data categories.  
 
 
Figure 47. Mean trend assumed for respiratory medical visit rates, excluding visits to pharmacies. Dotted 
line illustrates the true temporal pattern, while the solid line indicates the assumed mean trend. 
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Part 3: All Spatial and Temporal Covariance Plots Used 
 
  This section includes figures of all spatial and temporal covariance plots used for 
each data category in the study. Also included are the parameters that determine the 
covariance models (copied from a table in the main text). The spatial covariance plots share a 
striking resemblance, regardless of data category, as do the temporal covariance plots. 
 
Figure 48. Spatial covariance plot assumed for respiratory medical visit rates, all ages. Red dots 
represent covariance estimated at different distances, while the solid line indicates the assumed 
covariance model. 
 
 
Figure 49. Temporal covariance plot assumed for respiratory medical visit rates, all ages. Red dots 
represent covariance estimated at different distances, while the solid line indicates the assumed 
covariance model. 
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Figure 50. Spatial covariance plot assumed for cardiovascular medical visit rates, all ages. Red dots 
represent covariance estimated at different distances, while the solid line indicates the assumed 
covariance model. 
 
 
Figure 51. Temporal covariance plot assumed for cardiovascular medical visit rates, all ages. Red dots 
represent covariance estimated at different distances, while the solid line indicates the assumed 
covariance model. 
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Figure 52. Spatial covariance plot assumed for respiratory medical visit rates, exclusive to children under 
age 15. Red dots represent covariance estimated at different distances, while the solid line indicates the 
assumed covariance model. 
 
Figure 53. Temporal covariance plot assumed for respiratory medical visit rates, exclusive to children 
under age 15. Red dots represent covariance estimated at different distances, while the solid line indicates 
the assumed covariance model. 
 
 
Figure 54. Spatial covariance plot assumed for respiratory medical visit rates, excluding visits made to 
pharmacies. Red dots represent covariance estimated at different distances, while the solid line indicates 
the assumed covariance model. 
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Figure 55. Temporal covariance plot assumed for respiratory medical visit rates, excluding visits made to 
pharmacies. Red dots represent covariance estimated at different distances, while the solid line indicates 
the assumed covariance model. 
 
Category of Data Covariance Model 
General covariance 
model 
cX(r, τ) = c01 exp[-(3r/ar1)] exp[-(3τ/at1)] + c02 exp[-(3r/ar2)] exp[-
(3τ /at2)2] 
Respiratory diseases, 
all ages 
cX(r, τ) = 7.1 exp[-(3r/0.35)] exp[-(3τ/89)] + 2.9 exp[-(3r/9)] 
exp[-(3τ /90)2] 
Cardiovascular 
diseases, all ages 
cX(r, τ) = 7.3 exp[-(3r/0.45)] exp[-(3τ/99)] + 3.2 exp[-(3r/15)] 
exp[-(3τ /100)2]  
Respiratory diseases, 
children under 15 
cX(r, τ) = 6.0 exp[-(3r/0.4)] exp[-(3τ/125)] + 3.5 exp[-(3r/0.7)] 
exp[-(3τ /160)2]  
Respiratory diseases, 
all ages, no 
pharmacies 
cX(r, τ) = 7.1 exp[-(3r/0.3)] exp[-(3τ/99)] + 3 exp[-(3r/7)] exp[-
(3τ /100)2] 
Table 9. Covariance models, where r is the spatial lag, τ is the temporal lag, ar is the spatial range, and at 
is the temporal range. The lags specify the distance between the two space-time points whose covariance 
is measured, and the ranges indicate the distance at which 95% of the covariance between points at the 
same location has dissipated. A further description of the parameters of these equations is included under 
the methods section. 
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Appendix 4: Verification of BME-Estimated Values with Crude Values 
 
These estimation maps were derived through the BME method (described earlier). A 
sampling of maps is presented with the observed health rates plotted over the BME estimated 
values. This double-map is to compare the crude rates with the BME estimations.  
BME requires that immediately surrounding an observed data-point, the estimated 
health risks must be of equal value to the observed risk. However, some of the observed 
points look very different, color-wise, from the background estimates. This incongruence is 
due to the use of soft data (explained in the methods section). For a tract with a small 
population, the range of soft data points can be very large, leading to this incongruence. It is 
also apparent that observed values undergo a damping effect, as the range of estimated values 
is always curbed at a lower maximum than the range of values observed.  
  
  
Figure 56. Comparison of crude values and BME-estimated values, respiratory medical visits, February, 
2008. BME rates are given on a log-linear scale. Crude rates, like their BME counterparts, have been 
scaled up to account incomplete or loss of information, and both measures have been normalized to a 
year.   
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Figure 57. Comparison of crude and BME-estimated values, respiratory medical visits, April, 2008. BME 
rates are given on a log-linear scale. Crude rates, like their BME counterparts, have been scaled up to 
account incomplete or loss of information, and both measures have been normalized to a year.  
 
 
 
Figure 58. Comparison of crude and BME-estimated values, respiratory medical visits, June, 2008. BME 
rates are given on a log-linear scale. Crude rates, like their BME counterparts, have been scaled up to 
account incomplete or loss of information, and both measures have been normalized to a year.  
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Figure 59. Comparison of crude and BME-estimated values, respiratory medical visits, August, 2008. 
BME rates are given on a log-linear scale. Crude rates, like their BME counterparts, have been scaled up 
to account incomplete or loss of information, and both measures have been normalized to a year.  
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Appendix 5: Estimation Maps, BME 
 
 A complete set of estimation maps based on the BME method are included here. To 
reproduce the maps, contact Dr. Jens Thomsen of the Health Authority-Abu Dhabi, which 
has full data ownership rights, and contact Dr. Marc Serre of the Department of 
Environmental Sciences and Engineering at UNC Chapel Hill or Mejs Hasan for BME code.  
 Some maps which can be found in the main body of the thesis are repeated here. 
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Data Category 1: Respiratory Diseases, All Ages, All Medical Facilities 
 
 
Figure 60. February, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per 
year). Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper 
bounds.  
 
Figure 61. March, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
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Figure 62. April, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
 
 
Figure 63. May, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
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Figure 64. June, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
 
 
Figure 65. July, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
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Figure 66. August, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
 
 
Figure 67. September, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per 
year). Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper 
bounds.  
 86
 
Figure 68. October, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per year). 
Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper bounds.  
 
 
Figure 69. November, 2008 incidence rate of respiratory medical visits. (Visits per 100,000 people per 
year). Roads are shown as black lines. Rates are log-linearly distributed between the lower and upper 
bounds.  
 87
Data Category 2: Cardiovascular Medical Visits, All Ages, All Facilities 
 
 
Figure 70. April, 2008 incidence rate of cardiovascular medical visits. (Visits per 100,000 people per 
year). Rates are log-linearly distributed between the lower and upper bounds. Roads are shown as black 
lines.  
 
 
Figure 71. June, 2008 incidence rate of cardiovascular medical visits. (Visits per 100,000 people per year). 
Rates are log-linearly distributed between the lower and upper bounds. Roads are shown as black lines.  
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Figure 72. August, 2008 incidence rate of cardiovascular medical visits. (Visits per 100,000 people per 
year). Rates are log-linearly distributed between the lower and upper bounds. Roads are shown as black 
lines.  
 
 89
Data Category 3: Respiratory Medical Visits, Children Under 15, All Facilities 
 
 
Figure 73. April, 2008 incidence rate of respiratory medical visits amongst children. (Visits per 100,000 
children per year). Roads are shown as black lines. Rates are log-linearly distributed between the lower 
and upper bounds.  
 
Figure 74. June, 2008 incidence rate of respiratory medical visits amongst children. (Visits per 100,000 
children per year). Roads are shown as black lines. Rates are log-linearly distributed between the lower 
and upper bounds.  
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Figure 75. August, 2008 incidence rate of respiratory medical visits amongst children. (Visits per 100,000 
children per year). Roads are shown as black lines. Rates are log-linearly distributed between the lower 
and upper bounds.  
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Data Category 4: Respiratory Medical Visits, All Ages, All Facilities Excluding 
Pharmacies 
 
 
Figure 76. April, 2008 incidence rate of respiratory medical visits, excluding visits at pharmacies. (Visits 
per 100,000 people per year). Roads are shown as black lines. Rates are log-linearly distributed between 
the lower and upper bounds.  
 
 
Figure 77. June, 2008 incidence rate of respiratory medical visits, excluding visits at pharmacies. (Visits 
per 100,000 people per year). Roads are shown as black lines. Rates are log-linearly distributed between 
the lower and upper bounds.  
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Figure 78. August, 2008 incidence rate of respiratory medical visits, excluding visits at pharmacies. 
(Visits per 100,000 people per year). Roads are shown as black lines. Rates are log-linearly distributed 
between the lower and upper bounds.  
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Appendix 6: Estimation Maps, Waller Model 
 
 A complete set of estimation maps based on the Waller model and executed in 
WinBUGS method are included here. To reproduce the maps, contact Dr. Jens Thomsen of 
the Health Authority-Abu Dhabi, which has full data ownership rights, and contact Dr. Marc 
Serre of the Department of Environmental Sciences and Engineering at UNC Chapel Hill or 
Mejs Hasan for Waller model code compatible with WinBUGS.  
 Some maps which can be found in the main body of the thesis are repeated here. 
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Data Category 1: Respiratory Diseases, All Ages, All Medical Facilities 
 
 
Figure 79. February, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits 
per 100,000 people per year). Roads are shown as black lines.  
 
 
Figure 80. March, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
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Figure 81. April, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
 
 
Figure 82. May, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
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Figure 83. June, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
 
 
Figure 84. July, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
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Figure 85. August, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits per 
100,000 people per year). Roads are shown as black lines.  
 
 
Figure 86. September, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits 
per 100,000 people per year). Roads are shown as black lines.  
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Figure 87. October, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits 
per 100,000 people per year). Roads are shown as black lines.  
 
 
Figure 88. November, 2008 incidence rate of respiratory medical visits from Waller model output. (Visits 
per 100,000 people per year). Roads are shown as black lines.  
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